跳至主要内容
临床试验/ITMCTR2200006728
ITMCTR2200006728尚未招募未知

Study on the effect and mechanism of Erzhitiangui granule in improving the pregnancy outcome of advanced age patients with IVF infertility

Reproductive Hospital Affiliated to Shandong University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
35 至 42(—)
性别
Female

入选标准

  • ? Age 35-42 years old; FSH <12mIU/ml, the number of antral follicles > 5; ? Patients with tubal factors to undergo IVF; ? Normal liver and kidney function, no gynecological and other systemic diseases.

排除标准

  • ?Uterine malformation,including single horn uterus, uterine cavity adhesion;?Severe diseases, including diseases of cardiovascular, cerebrovascular, liver, kidney and hematopoietic systems, and mental illness; ?Received hormone drug therapy within last six month; ? Allergic to the drug used in this study; ?Taken other traditional Chinese medicine treating infertility in the past three month.

研究者

发起方
Reproductive Hospital Affiliated to Shandong University

相似试验